Back to funds
View filing
GSK plc
institutionalUpdated 29 days agoManaged by Gsk Plc • Latest filing Q2 2026
Portfolio value
$602.2M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $799M |
| Q1 2026 | $599.2M |
| Q2 2026 | $602.2M |
Top holdings
13 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CRSP CRISPR THERAPEUTICS AG | $175.7M | 3.22M | 29.17% | — |
| 2 | W WVE WAVE LIFE SCIENCES LTD | $106M | 18.25M | 17.60% | — |
| 3 | V VIR VIR BIOTECHNOLOGY INC | $87.1M | 8.55M | 14.47% | — |
| 4 | B BNTX BIONTECH SE | $82.8M | 889.8K | 13.75% | — |
| 5 | I IDYA IDEAYA BIOSCIENCES INC | $49.7M | 1.33M | 8.25% | — |
| 6 | C CYTK CYTOKINETICS INC | $29M | 340.4K | 4.82% | — |
| 7 | L LYEL LYELL IMMUNOPHARMA INC | $21.3M | 1.51M | 3.53% | — |
| 8 | ? N/A SPERO THERAPEUTICS INC | $20.3M | 9.19M | 3.37% | — |
| 9 | N NKTX NKARTA INC | $8.9M | 3.15M | 1.48% | — |
| 10 | ? N/A FULCRUM THERAPEUTICS INC | $6.5M | 1.79M | 1.09% | — |
| 11 | B BCYC BICYCLE THERAPEUTICS PLC | $6.5M | 1.53M | 1.08% | — |
| 12 | C CVRX CVRX INC | $5.2M | 1.01M | 0.86% | — |
| 13 | R RGNX REGENXBIO INC | $3.3M | 271.5K | 0.54% | — |